Pharmacy cannabis adoption could reshape patient access, prescribing and supply across Europe, but regulation, training and reimbursement remain decisive.
Cannabinoid sleep evidence is promising but uneven: what trials say on THC, CBD, insomnia, safety and clinical use in Britain today for British patients.
Practical guidance on how to avoid cannabis drug interactions, from CYP enzymes and high-risk medicines to safer conversations with your pharmacist first.
How CBD novel foods work in the UK: the FSA process, safety evidence, authorisation status and what brands, retailers and consumers need to check first.
Pharmacy cannabis adoption could reshape patient access, prescribing and supply across Europe, but regulation, training and reimbursement remain decisive.
Cannabinoid sleep evidence is promising but uneven: what trials say on THC, CBD, insomnia, safety and clinical use in Britain today for British patients.
Practical guidance on how to avoid cannabis drug interactions, from CYP enzymes and high-risk medicines to safer conversations with your pharmacist first.
How CBD novel foods work in the UK: the FSA process, safety evidence, authorisation status and what brands, retailers and consumers need to check first.